Comment
Ezetimibe added to ongoing statin therapy reduced LDL cholesterol in primary hypercholesterolemia
Affiliations
- PMID: 12841712
Item in Clipboard
Comment
Ezetimibe added to ongoing statin therapy reduced LDL cholesterol in primary hypercholesterolemia
ACP J Club.
2003 Jul-Aug.
No abstract available
Comment on
-
Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia.Am J Cardiol. 2002 Nov 15;90(10):1084-91. doi: 10.1016/s0002-9149(02)02774-1. Am J Cardiol. 2002. PMID: 12423708 Clinical Trial.
Similar articles
-
Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.Am J Cardiol. 2009 Feb 1;103(3):369-74. doi: 10.1016/j.amjcard.2008.09.090. Epub 2008 Oct 30. Am J Cardiol. 2009. PMID: 19166691
-
Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.Am J Geriatr Pharmacother. 2005 Dec;3(4):218-28. Am J Geriatr Pharmacother. 2005. PMID: 16503317 Clinical Trial.
-
Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.J Womens Health (Larchmt). 2004 Dec;13(10):1101-7. doi: 10.1089/jwh.2004.13.1101. J Womens Health (Larchmt). 2004. PMID: 15650343
-
Ezetimibe: a novel option for lowering cholesterol.Expert Rev Cardiovasc Ther. 2003 May;1(1):11-21. doi: 10.1586/14779072.1.1.11. Expert Rev Cardiovasc Ther. 2003. PMID: 15030293 Review.
-
Statin and ezetimibe combination therapy in cardiovascular disease.Curr Opin Endocrinol Diabetes Obes. 2009 Apr;16(2):183-8. doi: 10.1097/MED.0b013e3283295297. Curr Opin Endocrinol Diabetes Obes. 2009. PMID: 19262375 Review.